Higher levels of INHBE expression have been observed in insulin resistance52, an early pathophysiologic process in metabolic disease, and, in our study, in hepatic steatosis and inflammation, which may partly reflect the insulin resistance associated with those conditions. The gene discussed is INHBE; the disease is fatty liver disease.